Antares Pharma, Inc.
ATRSDelisted May 24, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001016169
Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.
Holders of 5% or more of ATRS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Antares Pharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Antares Pharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Antares Pharma, Inc., newest first.
No Schedule 13D or 13G filings on Antares Pharma, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Antares Pharma, Inc. shares.
No Form 144 notices for Antares Pharma, Inc. are on file.